248 related articles for article (PubMed ID: 32867977)
1. Assessing the efficacy of a recombinant H9N2 avian influenza virus-inactivated vaccine.
Song CL; Liao ZH; Shen Y; Wang H; Lin WC; Li H; Chen WG; Xie QM
Poult Sci; 2020 Sep; 99(9):4334-4342. PubMed ID: 32867977
[TBL] [Abstract][Full Text] [Related]
2. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
[TBL] [Abstract][Full Text] [Related]
3. Enhanced cross-lineage protection induced by recombinant H9N2 avian influenza virus inactivated vaccine.
Wang Z; Li Z; Su X; Qiao Y; Fan W; Li H; Shi B; Qin T; Chen S; Peng D; Liu X
Vaccine; 2019 Mar; 37(13):1736-1742. PubMed ID: 30797637
[TBL] [Abstract][Full Text] [Related]
4. Generation of a reassortant avian influenza virus H5N2 vaccine strain capable of protecting chickens against infection with Egyptian H5N1 and H9N2 viruses.
Kandeil A; Moatasim Y; Gomaa MR; Shehata MM; El-Shesheny R; Barakat A; Webby RJ; Ali MA; Kayali G
Vaccine; 2016 Jan; 34(2):218-224. PubMed ID: 26620838
[TBL] [Abstract][Full Text] [Related]
5. A Dose-Response Study of Inactivated Low Pathogenic Avian Influenza H9N2 Virus in Specific-Pathogen-Free and Commercial Broiler Chickens.
Kilany WH; Ali A; Bazid AH; El-Deeb AH; El-Abideen MA; Sayed ME; El-Kady MF
Avian Dis; 2016 May; 60(1 Suppl):256-61. PubMed ID: 27309065
[TBL] [Abstract][Full Text] [Related]
6. Influenza virus-like particles harboring H9N2 HA and NA proteins induce a protective immune response in chicken.
Li X; Ju H; Liu J; Yang D; Qi X; Yang X; Qiu Y; Zheng J; Ge F; Zhou J
Influenza Other Respir Viruses; 2017 Nov; 11(6):518-524. PubMed ID: 28752641
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza.
Zhao J; Yang H; Xu H; Ma Z; Zhang G
Virol J; 2017 Mar; 14(1):56. PubMed ID: 28302119
[TBL] [Abstract][Full Text] [Related]
8. Low pathogenic avian influenza (H9N2) in chicken: Evaluation of an ancestral H9-MVA vaccine.
Ducatez MF; Becker J; Freudenstein A; Delverdier M; Delpont M; Sutter G; Guérin JL; Volz A
Vet Microbiol; 2016 Jun; 189():59-67. PubMed ID: 27259828
[TBL] [Abstract][Full Text] [Related]
9. Enhancing immunogenicity and protective efficacy of inactivated avian influenza H9N2vaccine with recombinant chicken IFN-α in chicken.
Gan L; Tian Y; Zhao Y; Shan XQ; Zhou W; Xia BB; Chen J; Wang ML; Zhao J
Vet Microbiol; 2019 Jul; 234():77-82. PubMed ID: 31213275
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Newcastle disease virus expressing H9 HA protects chickens against heterologous avian influenza H9N2 virus challenge.
Nagy A; Lee J; Mena I; Henningson J; Li Y; Ma J; Duff M; Li Y; Lang Y; Yang J; Abdallah F; Richt J; Ali A; García-Sastre A; Ma W
Vaccine; 2016 May; 34(23):2537-45. PubMed ID: 27102817
[TBL] [Abstract][Full Text] [Related]
11. A two dose immunization with an inactivated reassortant H5N2 virus protects chickens against lethal challenge with homologous 2.3.2.1 clade and heterologous 2.2 clade highly pathogenic avian influenza H5N1 viruses.
Bhat S; Sood R; Shukla S; Khandia R; Pateriya AK; Kumar N; Singh VK; Kalaiyarasu S; Kumar M; Bhatia S
Vet Microbiol; 2018 Apr; 217():149-157. PubMed ID: 29615248
[TBL] [Abstract][Full Text] [Related]
12. A Comparison of Toll-Like Receptor 5 and 21 Ligands as Adjuvants for a Formaldehyde Inactivated H9N2 Avian Influenza Virus Vaccine in Chickens.
Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Shojadoost B; Petrik JJ; Nagy É; Sharif S
Viral Immunol; 2018 Nov; 31(9):605-612. PubMed ID: 30222508
[TBL] [Abstract][Full Text] [Related]
13. Inactivated H9N2 avian influenza virus vaccine with gel-primed and mineral oil-boosted regimen could produce improved immune response in broiler breeders.
Lee DH; Kwon JS; Lee HJ; Lee YN; Hur W; Hong YH; Lee JB; Park SY; Choi IS; Song CS
Poult Sci; 2011 May; 90(5):1020-2. PubMed ID: 21489949
[TBL] [Abstract][Full Text] [Related]
14. Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza.
Wu R; Chen Q; Zheng L; Chen J; Sui Z; Guan Y; Chen Z
Arch Virol; 2009; 154(8):1203-10. PubMed ID: 19543688
[TBL] [Abstract][Full Text] [Related]
15. Reverse genetics based rgH5N2 vaccine provides protection against high dose challenge of H5N1 avian influenza virus in chicken.
Bhatia S; Khandia R; Sood R; Bhat S; Siddiqui A; Jahagirdhar G; Mishra S; Mishra A; Pateriya AK; Kulkarni DD
Microb Pathog; 2016 Aug; 97():172-7. PubMed ID: 27296706
[TBL] [Abstract][Full Text] [Related]
16. A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates.
Song H; Nieto GR; Perez DR
J Virol; 2007 Sep; 81(17):9238-48. PubMed ID: 17596317
[TBL] [Abstract][Full Text] [Related]
17. Examination of the effects of virus inactivation methods on the induction of antibody- and cell-mediated immune responses against whole inactivated H9N2 avian influenza virus vaccines in chickens.
Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Bavananthasivam J; Nagy É; Petrik JJ; Sharif S
Vaccine; 2018 Jun; 36(27):3908-3916. PubMed ID: 29853199
[TBL] [Abstract][Full Text] [Related]
18. Protective efficacy of an inactivated vaccine against H9N2 avian influenza virus in ducks.
Teng Q; Shen W; Liu Q; Rong G; Chen L; Li X; Chen H; Yang J; Li Z
Virol J; 2015 Sep; 12():143. PubMed ID: 26377565
[TBL] [Abstract][Full Text] [Related]
19. Quick and improved immune responses to inactivated H9N2 avian influenza vaccine by purified active fraction of Albizia julibrissin saponins.
Sun H; Fei L; Zhu B; Shi M
BMC Vet Res; 2020 Nov; 16(1):427. PubMed ID: 33160337
[TBL] [Abstract][Full Text] [Related]
20. Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.
Swayne DE; Suarez DL; Spackman E; Jadhao S; Dauphin G; Kim-Torchetti M; McGrane J; Weaver J; Daniels P; Wong F; Selleck P; Wiyono A; Indriani R; Yupiana Y; Sawitri Siregar E; Prajitno T; Smith D; Fouchier R
J Virol; 2015 Apr; 89(7):3746-62. PubMed ID: 25609805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
